ECSP20013310A - Formulación que comprende material nanoestructurado, biocompatible y biocatalítico para el tratamiento de heridas e infecciones - Google Patents

Formulación que comprende material nanoestructurado, biocompatible y biocatalítico para el tratamiento de heridas e infecciones

Info

Publication number
ECSP20013310A
ECSP20013310A ECSENADI202013310A ECDI202013310A ECSP20013310A EC SP20013310 A ECSP20013310 A EC SP20013310A EC SENADI202013310 A ECSENADI202013310 A EC SENADI202013310A EC DI202013310 A ECDI202013310 A EC DI202013310A EC SP20013310 A ECSP20013310 A EC SP20013310A
Authority
EC
Ecuador
Prior art keywords
wounds
biocompatible
infections
treatment
formulation including
Prior art date
Application number
ECSENADI202013310A
Other languages
English (en)
Inventor
Tessy María López-Goerne
Original Assignee
Gomez Lopez Wenceslao
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gomez Lopez Wenceslao filed Critical Gomez Lopez Wenceslao
Publication of ECSP20013310A publication Critical patent/ECSP20013310A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0004—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/30—Copper compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/315—Zinc compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0095—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Composite Materials (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Formulación que comprende material nanoestructurado, biocompatible y biocatalítico que comprende un ácido sólido que consiste en óxidos mixtos de sílice y titania (Ti02-Si02); soporte en su matriz dispersa: cobre, plata, oro, hierro, rutenio, paladio, zinc, manganeso, iridio y / o metales de platino en concentraciones mínimas, para su uso en el tratamiento de heridas e infecciones.
ECSENADI202013310A 2017-07-20 2020-02-20 Formulación que comprende material nanoestructurado, biocompatible y biocatalítico para el tratamiento de heridas e infecciones ECSP20013310A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762534747P 2017-07-20 2017-07-20

Publications (1)

Publication Number Publication Date
ECSP20013310A true ECSP20013310A (es) 2020-09-30

Family

ID=65015927

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSENADI202013310A ECSP20013310A (es) 2017-07-20 2020-02-20 Formulación que comprende material nanoestructurado, biocompatible y biocatalítico para el tratamiento de heridas e infecciones

Country Status (15)

Country Link
US (1) US20200147259A1 (es)
EP (1) EP3654944B1 (es)
JP (1) JP2020528084A (es)
KR (1) KR20200091378A (es)
CN (1) CN111093630A (es)
BR (1) BR112020001041A2 (es)
CA (1) CA3070322A1 (es)
CL (1) CL2020000129A1 (es)
CO (1) CO2020001810A2 (es)
EC (1) ECSP20013310A (es)
ES (1) ES3061084T3 (es)
PE (1) PE20211248A1 (es)
PL (1) PL3654944T3 (es)
SG (1) SG11202000506VA (es)
WO (1) WO2019016724A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102920393B1 (ko) 2024-01-15 2026-01-30 주식회사 바우 상하 이동식 칸막이를 가진 책상

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04231062A (ja) * 1990-09-18 1992-08-19 Create Medic Kk 抗菌性医療用品
US6333093B1 (en) * 1997-03-17 2001-12-25 Westaim Biomedical Corp. Anti-microbial coatings having indicator properties and wound dressings
US6582713B2 (en) * 2000-04-06 2003-06-24 Univ. Of Colorado - Colorado Springs Compositions and methods for promoting wound healing
GB2392913B (en) * 2002-09-11 2007-04-04 Johnson & Johnson Medical Ltd Wound dressings comprising complexes of oxidised celluloses with silver
US20080089839A1 (en) * 2004-09-16 2008-04-17 Guo-Quan Lu Preparation of Stable High Concentration Coloidal Metal Particulate System
GB2432529B (en) * 2005-11-25 2008-04-23 Univ Feng Chia Antimicrobial compositions and wound dressings
US7517536B2 (en) * 2005-11-25 2009-04-14 Feng Chia University Antimicrobial compositions and wound dressings
US7820583B2 (en) * 2006-08-24 2010-10-26 Millennium Inorganic Chemicals, Inc. Nanocomposite particle and process of preparing the same
WO2008144616A1 (en) * 2007-05-18 2008-11-27 Heidi Kay Lipid raft, caveolin protein, and caveolar function modulation compounds and associated synthetic and therapeutic methods
DE102007030103A1 (de) * 2007-06-28 2009-01-02 Bode Chemie Gmbh & Co. Kg Verwendung einer synergistischen Zusammensetzung als therapeutisches oder kosmetisches Mittel
IT1391668B1 (it) * 2008-07-23 2012-01-17 Universita' Degli Studi Di Trieste Materiali nanocompositi basati su nanoparticelle metalliche stabilizzate con polisaccaridi a struttura ramificata.
WO2010150036A1 (en) * 2009-06-24 2010-12-29 Universidad Autonoma Metropolitana - Xochimilco Sol-gel nanostructured and biocompatible platinum-titania and platinum- silica biocatalysts nanostructured and biocompatible for use in cancer treatment
WO2011045627A1 (en) * 2009-10-12 2011-04-21 Arce Macias, Carlos, Francisco Viricide agents having nanostructured biocatalysts materials of titanium dioxide (tio2) and silicium dioxide (si02) with platinum and iridium modified and dispersed on the surface
WO2011045623A1 (en) * 2009-10-12 2011-04-21 Arce Macias, Carlos Francisco Titanium dioxide nanostructured materials comprising silver and their use as antimicrobials
KR101020041B1 (ko) * 2010-05-10 2011-03-09 박문선 Ｐｔ-Ａｇ-ＣｙＤ（Ａｇ-팽윤성수지） 항균제 및 이의 제조방법
US9125892B2 (en) * 2014-02-03 2015-09-08 George D. Petito Composition for reduced scar formation of wounds

Also Published As

Publication number Publication date
WO2019016724A3 (en) 2019-02-28
PE20211248A1 (es) 2021-07-13
PL3654944T3 (pl) 2026-03-23
KR20200091378A (ko) 2020-07-30
US20200147259A1 (en) 2020-05-14
CA3070322A1 (en) 2019-01-24
WO2019016724A2 (en) 2019-01-24
JP2020528084A (ja) 2020-09-17
EP3654944B1 (en) 2025-11-26
EP3654944A2 (en) 2020-05-27
BR112020001041A2 (pt) 2020-07-21
CN111093630A (zh) 2020-05-01
CO2020001810A2 (es) 2020-05-29
ES3061084T3 (en) 2026-03-31
EP3654944A4 (en) 2021-08-25
EP3654944C0 (en) 2025-11-26
SG11202000506VA (en) 2020-02-27
CL2020000129A1 (es) 2020-11-20

Similar Documents

Publication Publication Date Title
CL2008003407A1 (es) Compuestos derivados de aril- y heteroarilcarbonilo de heterobiciclo sustituido; composicion farmaceutica; procedimiento de preparacion; y su uso en el tratamiento y/o prevencion de trastornos metabolicos, mediado por la inhibicion de la enzima hsd-1.
MX2012006628A (es) Microorganismos probioticos como agentes activos para mejorar el brillo de la piel.
CY1120392T1 (el) Αντιμικροβιακες συνθεσεις και σχετικες μεθοδοι χρησης
BRPI0821110B8 (pt) anticorpo de neutralização de anti-nr10/il31ra, composição farmacêutica compreendendo o referido anticorpo e uso do mesmo
CL2007003630A1 (es) Composicion farmaceutica que comprende vitamina c, vitamina e, luteina, zinc, acido graso omega-3 y cobre; metodo de elaboracion; y uso para el tratamiento y/o prevencion de la degeneracion macular relacionada con la edad (amd) y/o retinopatia diabet
NO20083780L (no) Topisk sammensetning omfattende en antibakteriell substans
UY30364A1 (es) Arilimidazolonas y ariltriazolonas sustituidas asi como su uso
NI201000044A (es) Bromhidrato de bupropión y aplicaciones terapéuticas
ECSP088811A (es) Compuestos orgánicos y sus usos
CL2008002042A1 (es) Compuestos derivados de heterociclos nitrogenados enlazados; y su uso en el tratamiento de la diabetes y desordenes metabolicos.
CL2008000875A1 (es) Compuestos derivados de imidazolidin-2-ona; proceso de obtencion; composicion farmaceutica; y uso en el tratamiento y/o profilaxis de enfermedades tales como dislipidemia, diabetes, enfermedades inflamatorias, entre otras.
CL2019003670A1 (es) Composición que comprende manosa oligosacárido y proceso para realizarla y uso de esta.
MY190687A (en) Antimicrobial compositions and related methods of use
MX390157B (es) Compuestos para el tratamiento de enfermedad respiratoria bovina o porcina.
EP2515912A4 (en) Pharmaceutical composition comprising vitamin d analogue and cosolvent-surfactant mixture
CL2008003799A1 (es) Composicion farmaceutica que comprende raloxifeno en forma de tableta de liberacion inmediata; util para el tratamiento y/o prevencion de la osteoporosis.
CO2020001810A2 (es) Formulación que comprende material nanoestructurado, biocompatible y biocatalítico para el tratamiento de heridas e infecciones
ES2895910T3 (es) Composiciones multifásicas
PA8806501A1 (es) Triazolotriazinas y triazolopirazinas y su uso
MX363279B (es) Composiciones de dibromomalonamida y sus usos como biocidas.
UY33662A (es) Combinaciones que comprenden inhibidores de dhodh e inhibidores de cox
ES2481450T3 (es) Proteasas específicas de ubiquitina responsables de la estabilidad de mcl 1 y su utilización
SE0403014D0 (sv) New protein formulation
GT200600106A (es) Agentes endoparasiticidas
UY29387A1 (es) Imidazoles sustituidos con heterociclilamida.